The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at Failure

Little is known about the functional relationship of delaying second-line treatment initiation for human immunodeficiency virus–positive patients and mortality, given a patient’s immune status. We included 7,255 patients starting antiretroviral therapy during 2004–2017, from 9 South African cohorts,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Epidemiol
Main Authors: Bell-Gorrod, Helen, Fox, Matthew P, Boulle, Andrew, Prozesky, Hans, Wood, Robin, Tanser, Frank, Davies, Mary-Ann, Schomaker, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Contribution
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523585/
https://ncbi.nlm.nih.gov/pubmed/32219384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwaa049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados